27 June 2007
National Institute for Health and Clinical Excellence
The Health Committee would like to announce the witnesses for the third oral evidence session of its inquiry into the National Institute for Health and Clinical Excellence.
Thursday 12 July
Wilson Room, Portcullis House
at 10.00 am
Dr Gill Morgan, Chief Executive, NHS Confederation
Dr Tim Crayford, Association of Directors of Public Health, and head of public health at Croydon PCT
Dr Lise Llewellyn, Chief Executive, Berkshire East PCT
at 11.15 am
Richard Barker, Director General, Association of the British Pharmaceutical Industry (ABPI)
Dr David Brickwood, Vice-President, International and Government Affairs - Europe. Johnson & Johnson
Eddie Gray, General Manager and Senior Vice President, GlaxoSmithKline UK
Further evidence sessions are expected to take place in the autumn. Details will be announced in due course.
The uncorrected transcript of each evidence session is placed on the Health Committee website as soon as possible after the meeting - www.parliament.uk/healthcom
Dates and times of all public House of Commons Select Committee meetings can be found at www.parliament.uk/what_s_on/hoc_news3.cfm
Members of the public and representatives of the press will be admitted to these meetings. Meetings may be held either in the Palace of Westminster or Portcullis House, and there are often last minute changes. Those wishing to attend are advised to check the venue by contacting the House of Commons Public Information office on 020 7219 4272 the day before the meeting.
The Health Committee is a Select Committee of the House of Commons. It is appointed under Standing Order No.152 to examine the expenditure, administration and policy of the Department of Health and associated public bodies. The Committee has the power to send for persons, papers and records.
Please note that the Health Committee is unable to investigate individual cases